Leishmaniasis and Chagas disease, caused by the kinetoplastid parasites Leishmania spp
and Trypanosoma cruzi, respectively, are among the most important parasitic diseases …

This study aimed to evaluate the efficacy of glucantime and amphotericin B (AmB)
encapsulated in niosome against cutaneous leishmaniasis (CL) using in vitro and in vivo …

Sodium stibogluconate (SSG, Pentostam) and meglumine antimoniate (MA, Glucantime) are
two antimonials that are widely used to treat cutaneous leishmaniasis (CL), but the relative …

The strategy for improving the treatment of leishmaniasis by the World Health Organization,
is the development of new drugs and combination therapy. The aim of this survey was to …

Leishmaniasis is defined as a cluster of infectious diseases caused by protozoan parasites
of the genus Leishmania. It is recognized worldwide as a major health problem, showing …

There is no effective treatment modality available against different forms of leishmaniasis.
Therefore, the aim of this study was to improve the penetration and efficacy of selenium and …

Ursolic acid (UA) is a triterpene with a broad array of pharmacological activities. In
leishmaniasis, UA killed different species of parasites, and it was active in the experimental …

Dogs are the main reservoir for Leishmania infantum, manifesting from a subclinical to a
fatal disease. Limited treatments are available, although new antiparasitics and …

Abstract Background Cutaneous Leishmaniasis (CL) is the most common form of
leishmaniasis. CL can be divided into two major groups: acute CL (ACL) and chronic CL …

Background: We aimed to design a different method of drug delivery for increased transfer of
the choice drug (meglumine antimoniate) within the host cells. Therefore, listeriolysin O …